Tight Versus Liberal Blood Glucose Control in Patients With Diabetes in the ICU: A Meta-Analysis of Randomized Controlled Trials

J Intensive Care Med. 2024 Dec;39(12):1250-1255. doi: 10.1177/08850666241255671. Epub 2024 May 16.

Abstract

Introduction: Glycemia is an important factor among critically ill patients in the intensive care unit (ICU). There is conflicting evidence on the preferred strategy of blood glucose control among patients with diabetes in the ICU. We aimed to conduct a meta-analysis comparing tight with liberal blood glucose in critically ill patients with diabetes in the ICU. Methods: We systematically searched PubMed, Embase, and Cochrane Central for randomized controlled trials (RCTs) comparing tight versus liberal blood glucose control in critically ill patients with diabetes from inception to December 2023. We pooled odds-ratios (OR) and 95% confidence intervals (CI) with a random-effects model for binary endpoints. We used the Review Manager 5.17 and R version 4.3.2 for statistical analyses. Risk of bias assessment was performed with the Cochrane tool for randomized trials (RoB2). Results: Eight RCTs with 4474 patients were included. There was no statistically significant difference in all-cause mortality (OR 1.11; 95% CI 0.95-1.28; P = .18; I² = 0%) between a tight and liberal blood glucose control. RoB2 identified all studies at low risk of bias and funnel plot suggested no evidence of publication bias. Conclusion: In patients with diabetes in the ICU, there was no statistically significant difference in all-cause mortality between a tight and liberal blood glucose control. PROSPERO registration: CRD42023485032.

Keywords: critical care; diabetes mellitus; glycemic control; insulin; intensive care units.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Blood Glucose* / analysis
  • Critical Care / methods
  • Critical Illness* / mortality
  • Critical Illness* / therapy
  • Diabetes Mellitus* / blood
  • Female
  • Glycemic Control
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Intensive Care Units
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic

Substances

  • Blood Glucose
  • Hypoglycemic Agents